10 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Pneumocystis pneumonia (PCP ... Toxoplasma gondii encephalitis ... Infections #OIs #HIVAIDS ... #IDSA #management ... #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Pneumocystis pneumonia (PCP ... Toxoplasma gondii encephalitis ... Infections #OIs #HIVAIDS ... #IDSA #management ... #pharmacology
An Algorithm for the Management of Seizures

The management of active seizures is algorithmic, starting with a
the Management ... Seizures The management ... Pharmacologic treatment ... The focus is on ... #Management #Emergency
Algorithm for the Treatment of Uremic Pruritus
Nonpharmacologic Treatments:
 • Daily topical emollient
 • Avoidance of extremes
Algorithm for the ... Evidence-Based Off-Label ... Pharmacologic Treatments ... uremia #itching #Algorithm ... #Treatment #management
The algorithm below shows how pre-test probability could be combined with various criteria to determine which
short course of treatment ... provide empiric treatment ... HSV encephalitis ... is proposed: #Management ... #Meningitis #Encephalitis
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Toxoplasma gondii Encephalitis ... IDSA #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #management #pharmacology ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Refer to product label ... for effective treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
The crusade against “Ab”Normal Saline continues.  This is a non-physiologic fluid that can harm our
this post will focus ... its Chloride (Cl ... #criticalcare #management ... #diagnosis #treatment ... #pharmacology #
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
recommended for KS treatment ... IDSA #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Prevention and Treatment of Pneumocystis Pneumonia (PCP) in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
Prevention and Treatment ... Pneumocystis Pneumonia (PCP ... IDSA #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #management #pharmacology